SmartestCrowd
Organizations
Orgs
No organizations
Projects
No projects
0
0
Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy | Scientific Reports - Nature.com
10/7/22 at 9:15am
Organization
Nature.com
54 words
0
Comments
Scientific Reports - Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy
Health
Infectious Diseases
Serum IL-1β
hepatitis B virus reactivation
Scientific Reports - Nature.com Scientific Reports - Serum IL-1β
You are the first to view
https://www.nature.com/articles/s41598-022-21315-z
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...